جست‌وجوی استاد و پژوهشگر

Kai Zhangمشاهده پروفایل

دانشیار

• Neuroscience
• Neurologic disorders
• Imaging
• +۷ مورد دیگر

Kai Zhang is an Associate Professor and Associate Head & Director of Graduate Studies in the Department of Biochemistry at the University of Illinois Urbana-Champaign, within the School of Molecular and Cellular Biology. He holds affiliations with the Beckman Institute for Advanced Science and Technology, Neuroscience Program, and the Cancer Center at Illinois. His research focuses on signal transduction mechanisms in cell fate determination and disease contexts, leveraging optogenetics and live-cell imaging to study growth factor signaling, axonal transport, and mitochondrial dynamics. Education: B.S. (2002) from University of Science and Technology of China; Ph.D. (2008) from UC Berkeley; Postdoc (2009–2014) at Stanford University. Research Interests: Optogenetic Control: Spatiotemporal regulation of signaling pathways (e.g., MAPK, PI3K-AKT) using light-activated systems, with applications in cell differentiation and embryonic development. Axonal Transport: Investigating defects in neurological disorders (e.g., Alzheimer’s, ALS) using microfluidic devices and live imaging to track cargo trafficking. Mitochondrial Biology: Developing light-based tools to modulate mitochondrial function and study metabolic diseases like NASH. Lab Activities: The Zhang Lab recruits students/postdocs in biochemistry, biophysics, and neuronal biology, emphasizing interdisciplinary approaches. Recent work includes optogenetic modulation of RIPK3-driven cell death and Arc protein secretion mechanisms.

• Cancer Immunology
• Oncology
• Immunotherapy
• +۳ مورد دیگر

Dr. Jamie Honeychurch is a Senior Lecturer in the Division of Cancer Sciences at the University of Manchester, leading research on combining radiotherapy and immunotherapy to enhance anti-tumor immunity. They are affiliated with the Targeted Therapy Group and Manchester Cancer Research Centre. Responsibilities include supervising students from BSc to PhD levels, contributing to the MRes Oncology Programme as Deputy Director and Tutorial Unit Lead, and teaching on multiple postgraduate programs including MSc Clinical Immunology and MBChB. Research focuses on onco-immunology, particularly radiation-enhanced T-cell activity, immunogenic cell death (ICD), and HMGB1's role in tumor immunity. Methodological expertise includes flow cytometry, in vivo tumor models, and immune assays. Public engagement activities include science outreach at Manchester Museum and community festivals. Teaching roles span undergraduate and postgraduate programs, with involvement in admissions and academic advising. Committee memberships include the Manchester Immuno-Oncology Group and British Association for Cancer Research.

Yanbo Guoمشاهده پروفایل

استادیار

• Renal Transplantation
• Uro-oncology
• Surgical Innovation
• +۳ مورد دیگر

Dr. Yanbo Guo serves as an Assistant Professor in Surgery at McMaster University and practices as an attending surgeon in Urology and Renal Transplantation at St. Joseph's Healthcare and Hamilton Health Sciences. His clinical expertise encompasses kidney and pancreas transplantation, complex urological procedures, and uro-oncology management. Education: Residency in Urology, McMaster University Advanced Fellowship in Kidney and Pancreas Transplantation, University of Western Ontario Dr. Guo's research program focuses on renal transplantation optimization , urological oncology , and surgical innovation . His work bridges clinical practice and technological advancement, particularly in donor kidney assessment protocols (including the Canadian Anatomic Kidney Score), machine learning applications for recurrence prediction, and novel preservation techniques. Recent publications demonstrate significant contributions to point-of-care diagnostics for transplant recipients and robotic surgical training methodologies. Analysis of his 15 most recent publications reveals dominant themes in transplantation medicine (47%), urological oncology (20%), and surgical technology (13%), with emerging interdisciplinary work in public health (13%) and materials science (7%). His research consistently appears in high-impact journals including Journal of Urology , Transplantation , and European Urology . Professional Affiliations: St. Joseph's Healthcare, Hamilton (Urology and Renal Transplantation) Hamilton Health Sciences (Urology and Renal Transplantation)

Fabin Dangمشاهده پروفایل

استادیار

• Cancer metabolism
• Antitumor immunity
• Cell death pathways
• +۵ مورد دیگر

Fabin Dang, PhD is an Assistant Professor in the Department of Genetics and Genome Sciences at Case Western Reserve University School of Medicine and a member of the Molecular Oncology Program at the Case Comprehensive Cancer Center. He joined the institution in June 2024 after completing his postdoctoral training and serving as an Instructor at Harvard Medical School. Dr. Dang earned his PhD in Biochemistry and Molecular Biology from the University of Chinese Academy of Sciences in 2017. Following this, he completed postdoctoral training at Beth Israel Deaconess Medical Center, Harvard Medical School from September 2017 to May 2021, and then served as an Instructor in the Department of Pathology at the same institution from June 2021 to May 2024. Dr. Dang's research primarily focuses on understanding the intricate crosstalk between cancer metabolism and antitumor immunity. His laboratory investigates how metabolic status of cancer and immune cells influences antitumor immunity through protein post-translational modifications, intracellular trafficking of membrane proteins, and epigenetic regulation in tumorigenesis. His ultimate goal is to develop novel targeted therapeutic strategies for clinical translation to combat cancer. His publication record demonstrates significant contributions to understanding cell death pathways, cancer metabolism, and immune regulation. His recent work explores palmitoylation and phosphorylation in inflammasome activation, metabolic regulation of cell death, and mechanisms of drug resistance in cancer. Dr. Dang has been actively involved in research collaborations with prominent institutions including Harvard Medical School and Beth Israel Deaconess Medical Center. His work spans multiple disciplines including molecular oncology, immunometabolism, and cell signaling pathways relevant to cancer therapy.

• Molecular Biology
• Cancer Biology
• Pharmacology
• +۳ مورد دیگر

Dr. Anna Lenart-Boroń is an academic at Maria Curie-Skłodowska University's Faculty of Biology and Biotechnology. She completed her habilitation proceedings in 2018, earning the degree of habilitated doctor in the field of biological sciences. Her research focuses on molecular biology, particularly exploring therapeutic agents like coumarins in combination therapy for gliomas. Her habilitation thesis, titled Therapeutic potential of coumarins in combination therapy with temozolomide in eliminating human glioma cells via programmed cell death , reflects her expertise in cancer biology and pharmacological approaches to neurooncology.

• Pharmacology
• Molecular Biology
• Neuroscience
• +۳ مورد دیگر

Dr. Adrian Wiater is a Professor at the Faculty of Biology and Biotechnology, Maria Curie-Skłodowska University (UMCS) in Lublin. He completed his habilitation in biological sciences (discipline of biology) in 2013, with his work focusing on molecular mechanisms in cancer research. Research Interests : His work centers on pharmacology and molecular biology, particularly the role of TrkB receptor pathways in programmed cell death of human glioma cells. Key areas include cancer biology, drug development, and cellular signaling. Academic Contributions : While no specific awards or student advisement details are mentioned in the text, his habilitation process involved a committee from UMCS and other Polish institutions, reflecting his collaborative academic engagement.

Rich Grinerمشاهده پروفایل

دانشیار

• Pharmacology
• Cell Biology
• Cancer Research
• +۳ مورد دیگر

Rich Griner is an Associate Professor and Department Chair of Biological Sciences at Georgia Regents University within the College of Science and Mathematics. With academic appointments spanning administration and research, Dr. Griner has been instrumental in shaping university strategy through committee leadership. Ph.D. in Pharmacology (University of Georgia, 1994) B.S. in Biology (University of Georgia, 1987) Research Interests: Dr. Griner's work spans pharmacological mechanisms in cancer cell death, toxicity profiling of natural compounds, antibiotic resistance patterns in veterinary pathogens, and fundamental cellular processes like Rab protein interactions in membrane trafficking. His publications reflect a focus on translational biomedical research bridging molecular biology and therapeutic development. Publication Trends: Analysis of Dr. Griner's scholarly output reveals a consistent focus on pharmacological interventions in cellular systems, with particular emphasis on apoptosis induction in cancer models (2014), toxicity assessment of plant-derived compounds (2013), and mechanistic studies of nucleotide analog effects on epithelial cells (2001). His earlier Rab protein research (2001) established foundational work in cellular trafficking mechanisms. Awards & Recognition: 2010 - Named Most Valuable Professor 2010 - Outstanding contributions as strategic planning subcommittee chair Academic Service: Dr. Griner has served on multiple institutional committees including the Intramural Grants Program Review Committee (2016), Biological Sciences Academic Advisory Committee (2015-2016), and search committees for academic leadership positions in dental and STEM education sectors.

Vadivel Ganapathyمشاهده پروفایل

استاد

• Cancer Biology
• Anticancer Drug Development
• Gut Microbiome-Host Interaction
• +۴ مورد دیگر

Vadivel Ganapathy, Ph.D., is a Professor in the Department of Cell Biology and Biochemistry at the School of Medicine, Texas Tech University Health Sciences Center (TTUHSC) in Lubbock, Texas. His research integrates molecular mechanisms of disease with translational therapeutic development across cancer biology, microbiome interactions, and retinal pathophysiology. Education Ph.D. in Biochemistry, University of Madras, India Research Focus Dr. Ganapathy's program centers on four pillars: (1) Targeting amino acid transporters like SLC6A14 for novel anticancer therapies in colon, pancreatic, and breast cancers; (2) Elucidating gut microbiome-host communication via short-chain fatty acid transporters (SLC5A8) and receptors (GPR109A/GPR43) in colonic inflammation and carcinogenesis; (3) Investigating hemochromatosis-driven cancer progression through iron overload mechanisms; and (4) Studying retinal iron homeostasis in diabetic retinopathy and macular degeneration. His approach combines molecular biology, metabolomics, and animal models to identify druggable targets. Publication Trends Analysis of 15 recent publications (2024-2025) reveals intensifying focus on transporter-targeted nanomedicine for cancer therapy, particularly SLC6A14/SLC38A5 inhibition in glutamine-addicted tumors. Significant work explores microbiome-derived metabolites (butyrate, ketones) in colitis-cancer axis regulation and iron dysregulation in diabetic complications. Emerging themes include ferroptosis induction via transporter blockade and GPR109A-mediated tumor suppression through p53 activation. Research Infrastructure Dr. Ganapathy leads an active laboratory at TTUHSC investigating nutrient transporter biology across disease contexts. His team employs CRISPR, metabolomics, and transgenic mouse models to develop therapeutic strategies targeting cancer metabolism, microbiome-host interfaces, and retinal iron pathology, with recent emphasis on nanoparticle-based drug delivery systems.

Elin Chorellمشاهده پروفایل

دانشیار

• Type 2 Diabetes Mechanisms
• Metabolomics
• Lipidomics
• +۶ مورد دیگر

Elin Chorell is an Associate Professor at Umeå University's Department of Public Health and Clinical Medicine, specifically within the Section of Endocrinology and Diabetes. Her research qualifications include the Swedish academic title of Docent, reflecting her significant contributions to her field. Dr. Chorell's primary research interests focus on identifying mechanisms underlying the development and remission of type 2 diabetes. Her work spans molecular metabolism, lipid metabolism, and multivariate bioinformatics, with a particular emphasis on metabolomics and lipidomics approaches. She has conducted extensive research on ethnic differences in metabolism, especially comparing Black and White South African populations, and how these differences relate to diabetes risk and insulin sensitivity. Analysis of her recent publications reveals a strong trend toward multi-omics approaches in diabetes research, with particular focus on lipid metabolism, cardiovascular risk factors, and ethnic variations in metabolic responses. Her work frequently employs metabolomic and lipidomic profiling to understand the molecular mechanisms of insulin resistance and diabetes progression. A notable aspect of her research program is the attention to population-specific risk factors, particularly in African populations which have often been underrepresented in metabolic research. Dr. Chorell is actively involved in several major research projects, including "Remission of type 2 diabetes becomes possible through eHealth" (2022-2028), "What happens to the human body when adhering to a ketogenic diet?" (2015), and "VIPVIZA" (2013-2027). Her research often involves collaborations across multiple institutions and countries, particularly with South African researchers. Her teaching activities primarily focus on molecular metabolism, lipid metabolism, and multivariate bioinformatics, contributing to the education of future researchers and clinicians in these specialized areas.

Sebastian Greissمشاهده پروفایل

پژوهشگر ارشد

• Genetic Code Expansion
• Neurobiology
• Unnatural Amino Acids
• +۴ مورد دیگر

Dr. Sebastian Greiss serves as a Chancellor's Fellow at the Centre for Integrative Physiology within the College of Medicine and Veterinary Medicine at the University of Edinburgh. His research focuses on developing and applying unnatural amino acid technology to study neuronal circuits in C. elegans , addressing fundamental questions about nervous system function. PhD, University of Dundee (2003-2008) Diploma in Biochemistry, University of Bayreuth (2002) Greiss pioneers genetic code expansion in multicellular organisms, creating light-activatable proteins through photo-caged amino acids to precisely control neuronal activity in freely moving C. elegans . His work bridges molecular engineering and systems neuroscience , using the worm's compact 302-neuron nervous system to decode how sensory inputs transform into behavioral outputs. Key innovations include tissue-specific proteomics and optogenetic control at single-protein resolution. His publication record shows consistent advancement in genetic code expansion from 2008-2014, transitioning from foundational work on sirtuins and apoptosis to breakthroughs in C. elegans and Drosophila genetic engineering. The research demonstrates increasing technical sophistication, moving from in vitro studies to in vivo applications in complex organisms with featured publications in Nature Biotechnology and Nature Chemical Biology . Greiss leads an active research group funded by the European Research Council, mentoring PhD students and postdoctoral fellows. His collaborative network spans the MRC Laboratory of Molecular Biology in Cambridge, Technical University Munich, and multiple Edinburgh research centers. Current work focuses on applying unnatural amino acid technology to dissect neuronal circuit function with unprecedented precision. Zhiyan Xi (PhD Student) Lloyd Davis (Postdoctoral Fellow) Andromachi Xypnitou (Research Associate)

Lisa Robertsمشاهده پروفایل

استاد

• Public Health
• Nursing
• Maternal and Child Health
• +۱۰ مورد دیگر

Lisa Roberts, DrPH, is a Professor in the School of Nursing and the School of Behavioral Health at Loma Linda University. She serves as Director of Research in the School of Nursing and is actively involved in graduate nursing education. Her academic roles include teaching qualitative research methods and mentoring doctoral students in dissertation research. Doctor of Public Health (DrPH), Loma Linda University, 2011 Master of Science (MS), Western University of Health Sciences, 2001 Bachelor of Science (BS), Excelsior College, 1994 Associate in Science (AS), Excelsior College, 1989 Dr. Roberts' research centers on public health and nursing interventions for vulnerable populations, with a focus on health disparities, maternal and child health, sickle cell disease, and global health. Her work integrates qualitative, mixed-methods, and systematic review approaches to explore reproductive decision-making, perinatal grief, cultural competence, and nurse well-being. She has conducted significant research in India, Haiti, and among African immigrant communities in the U.S. Her recent publications (2023–2025) highlight themes such as climate change impacts on maternal health, parental leave policies, mental health in low-income women, and bereavement care following perinatal loss. She employs rigorous qualitative and evidence synthesis methodologies, often publishing in journals focused on nursing, public health, and women's health. President, Sigma: Gamma Alpha Chapter (2018–2020) Vice President, Sigma: Gamma Alpha Chapter (2016–2018) Governance & Eligibility Chair, Sigma (2014–2016) Delegate, Sigma Biennial Convention (2017) Awards & Scholarships Reviewer, Sigma (2015–2017, 2021) Member, American Academy of Nursing (2019–present) Reviewer for journals including Sage Open , Public Health , Western Journal of Nursing Research , and International Journal of Childbirth Editorial Board Member, International Journal of Childbirth (2023–present) Dr. Roberts has led numerous research projects, including federal grants from HRSA and NIH, and institutional studies on nurse well-being, prostate cancer screening, and perinatal grief. She has advised on cultural competency for the HHS Office of Minority Health and served on the Rambo Committee supporting healthcare in India. Her teaching includes qualitative research methods and dissertation supervision, shaping the next generation of nursing scholars. She leads active research labs and teams focused on maternal health, nurse resilience, and global health equity. Projects such as the Grip Strength Study, Support After Stillbirth and Infant Death (SASAID), and the Fulbright Study on urbanization and women’s health in India reflect her interdisciplinary and international approach.

Zhi Shengمشاهده پروفایل

استادیار

• Cancer Biology
• Molecular Biology
• Glioblastoma
• +۵ مورد دیگر

Zhi Sheng, Ph.D., is an Assistant Professor at the Fralin Biomedical Research Institute at VTC and the Department of Internal Medicine, School of Medicine, Virginia Tech. His research is dedicated to finding new therapies for glioblastoma multiforme, a lethal and incurable brain cancer. Dr. Sheng's research interests lie at the intersection of molecular cancer biology and precision medicine. His laboratory investigates the molecular pathways governing cell survival and death in cancer, with a primary focus on overcoming drug resistance in glioblastoma. His work involves targeting specific genes like PIK3CB and exploring novel autophagy-regulating pathways, such as those involving long non-coding RNAs, to develop more effective treatments. A significant part of his research also involves the collaborative repurposing of the drug ACT1 to sensitize resistant glioblastoma cells to chemotherapy. His recent publications reveal a strong trend in identifying and validating new therapeutic targets for treatment-resistant brain cancers, particularly through the lens of molecular pathway disruption and combinatorial therapy. 2018 VTCSOM Outstanding Research Mentor Award Dr. Sheng is a highly regarded mentor, having advised several medical and graduate students, including multiple recipients of the prestigious St. Baldrick’s Foundation fellowship. His mentorship has been recognized with an official award, and he is praised for fostering a supportive environment that allows students to lead their research from grant writing to publication. Specific grants and funding sources are not mentioned in the text, but his active research program implies grant support. Dr. Sheng leads the Sheng Lab at the Fralin Biomedical Research Institute, where his team conducts cutting-edge research on glioblastoma and pediatric brain tumors, utilizing cell lines and molecular screening techniques.

• Cell Death
• Innate Immunity
• Inflammasomes
• +۱۲ مورد دیگر

Cornelius Y. Taabazuing is a Presidential Assistant Professor in the Department of Biochemistry and Biophysics at the Perelman School of Medicine, University of Pennsylvania. His research focuses on the molecular mechanisms of cell death pathways, particularly pyroptosis and apoptosis, and their roles in innate immunity, inflammation, and cancer immunotherapy. Education: B.S. in Biochemistry and Molecular Biology, University of Massachusetts Amherst, 2009 Ph.D. in Biological Chemistry, University of Massachusetts Amherst, 2015 Dr. Taabazuing's lab investigates supramolecular organizing centers (SMOCs), inflammasomes, and caspase activation in response to pathogens and genotoxic stress. His work integrates genetics, biochemistry, proteomics, and chemical biology to understand how danger signals trigger immune responses. Key research areas include the regulation of IL-1β and IL-18 maturation, GSDMD-mediated pyroptosis, and the role of PIDD in DNA damage-induced apoptosis. His recent publications (2022–2024) reveal trends in inflammasome diversity, caspase substrate specificity, and therapeutic targeting of cell death pathways. These studies span high-impact journals such as Science Advances , eLife , and Cell Reports , emphasizing both mechanistic insights and translational potential in autoinflammatory diseases and cancer. Scientific Awards: Presidential Assistant Professor, Perelman School of Medicine, University of Pennsylvania Dr. Taabazuing actively mentors graduate students and postdoctoral researchers, supports diversity in STEMM through advocacy and co-authored guides, and leads a collaborative, interdisciplinary research team. He is involved in educational outreach and has contributed to literature on equitable practices in science. The Taabazuing Lab is currently recruiting technicians, graduate students, and postdocs, indicating active grant-supported research and training programs. Laboratory and Team: The Taabazuing Lab includes undergraduate researchers, graduate students, and postdoctoral fellows. It operates as a dynamic, interdisciplinary team focused on cutting-edge questions in immunology and cell death, with strong collaborations across institutions.

Chengyu Liangمشاهده پروفایل

استاد

• Autophagy
• Cancer Biology
• Genomic Stability
• +۱۸ مورد دیگر

Chengyu Liang, M.D., Ph.D., is a Professor and Program Co-Leader in the Molecular and Cellular Oncogenesis Program at the Ellen and Ronald Caplan Cancer Center, The Wistar Institute, where she joined in 2020. Her research focuses on fundamental cellular mechanisms in cancer, inflammation, and infection, with an emphasis on autophagy, genomic stability, membrane trafficking, and virus-host interactions. Prior to joining Wistar, she was a tenured Associate Professor at the Keck School of Medicine, University of Southern California, where she established her lab in 2009. Education: M.D. from Qingdao University School of Medicine, China; Ph.D. in Genetics from SUNY Stony Brook; Postdoctoral training in Tumor Virology at Harvard Medical School. Affiliation: The Wistar Institute, Molecular and Cellular Oncogenesis Program, Ellen and Ronald Caplan Cancer Center. Dr. Liang’s research centers on the role of the tumor suppressor gene UVRAG in autophagy, DNA repair, and chromosomal stability. Her lab investigates how dysregulation of autophagy and related pathways contributes to melanoma, leukemia, and colorectal cancer progression and therapy resistance. A major focus is understanding UV-induced mutagenesis and the molecular basis of melanoma aggressiveness, including therapy resistance and immune evasion. The lab also explores how autophagy intersects with intracellular trafficking and viral persistence. The selected publications highlight a strong trajectory in understanding UVRAG’s multifaceted roles—from orchestrating membrane dynamics and autophagy to maintaining genomic integrity and enabling DNA repair. Collectively, her work bridges cancer biology, cell biology, and virology, with a translational focus on melanoma and treatment resistance. The research themes are highly interdisciplinary, involving molecular mechanisms of autophagy, stress response, and tumor suppression. Dr. Liang has trained numerous postdoctoral fellows and graduate students who have gone on to academic and industry positions. She leads an active research group including associate staff scientists, postdoctoral fellows, bioinformatics technicians, research assistants, and predoc trainees. The lab is actively recruiting motivated Ph.D. graduates. Her scientific contributions have been recognized through publications in high-impact journals such as Nature Cell Biology , Molecular Cell , and Nature Communications . While specific awards are not listed in the provided text, her research has been supported by institutional and external funding, enabling seed projects and high-risk/high-gain investigations. The Wistar Institute emphasizes translational research, and her work is aligned with bench-to-bedside strategies to improve melanoma therapies. The Liang Laboratory is exploring future directions in melanoma biology, aiming to identify biomarkers for early detection, understand differential therapy responses, and develop strategies to reprogram cancer cells toward differentiation. The lab’s work is central to advancing precision oncology and improving outcomes for melanoma patients.

• Plant Pathology
• Microbial Genetics
• Plant-Microbe Interactions
• +۳ مورد دیگر

Dr. Jessica Erickson is a Junior Group Leader at the University of Tübingen’s Center for Integrative Biological Signaling Studies (ZMBP), within the Department of General Genetics. Her research focuses on bacterial pathogens’ manipulation of plant apoplast environments, particularly through secreted proteins like those from Xanthomonas . She leads the Bacterial Apoplast Modulators Lab, studying virulence mechanisms and plant immune responses. Academically, she holds a Ph.D. from Martin Luther University Halle-Wittenberg and postdoctoral experience at the Leibniz Institute of Plant Biochemistry. Her career includes independent project leadership funded by the DFG’s Walter Benjamin Program. Current projects leverage molecular biology, biochemistry, and computational approaches, using Arabidopsis and Nicotiana benthamiana as model systems. Research interests include effector protein function, microtubule dynamics, and stromule formation in plant cells. Her lab collaborates broadly, with publications in PLOS Pathogens , Plant Cell Physiol , and Plant Physiology . Open positions exist for bachelor/master’s theses, emphasizing plant-bacteria interaction studies. Key grants include DFG support for her independent research and infrastructure for multiplex gene editing. The lab’s future work aims to dissect how bacterial proteins reprogram plant apoplast environments to enable disease progression.